Metastatic Urothelial Cancer Completed Phase 1 Trials for Enfortumab vedotin (DB13007)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0066157 (Metastatic Urothelial Cancer) | Completed | 1 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT03070990 | A Study of Enfortumab Vedotin in Japanese Subjects With Locally Advanced or Metastatic Urothelial Carcinoma | Treatment |